L-Asparaginase monotherapy for EBV-positive T/NK lymphoproliferative diseases: A pilot study

Journal of Medical and Dental Sciences

Volumn 62, Issue 1, 2015, Pages 1-9

  Jinta, Minako ^a   Imadome, Ken Ichi ^b   Komatsu, Honami ^a   Yoshimori, Mayumi ^a   Kurata, Morito ^a   Fujiwara, Shigeyoshi ^b   Miura, Osamu ^a   Arai, Ayako ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Asparagine synthetase; Epstein Barr virus positive T NK lymphoproliferative disease; L Asparaginase; Peripheral blood EBV DNA level

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; VIRUS DNA;

ADULT; BLOOD; CELL LINE; CHEMICALLY INDUCED; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECTS; DYSTONIA; EPSTEIN BARR VIRUS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NATURAL KILLER CELL; NEUTROPENIA; PATHOLOGY; PILOT STUDY; T LYMPHOCYTE; VIROLOGY; YOUNG ADULT;

ADULT; ANTINEOPLASTIC AGENTS; ASPARAGINASE; CELL LINE; DISEASE PROGRESSION; DNA, VIRAL; DYSTONIA; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NEUTROPENIA; PILOT PROJECTS; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84937107370     PISSN: 13428810     EISSN: 21859132     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Virelizier JL, Lenoir G, Griscelli C. Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion. Lancet. 1978; 2(8083): 231-4.
2. Ishihara S, Okada S, Wakiguchi H, Kurashige T, Morishima T, Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr. 1995; 84(11): 1271- 5.
3. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, et al. T-cell lymphomas containing Epstein- Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med. 1988; 318(12): 733-41.
4. Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001; 98(2): 280-6.
5. Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int. 2008; 58(4): 209-17.
6. Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, et al. Epstein-Barr virus (EBV)-associated T/NK lymphoproliferative diseases in non-immunocompromised hosts: prospective analysis of 108 cases. Blood. 2011.
7. Quintanilla-Martinez L, Kimura H, Jaffe ES. EBV-positive T-cell lymphoproliferative disorders of childhood. In: Jaffe E, Harris N, Stein H, editors. World Health Organization Classification of Tumors Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon IARC Press; 2008. p. 278-258.
8. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol. 2005; 80(1): 64-9.
9. Kawa K. Epstein-Barr virus--associated diseases in humans. Int J Hematol. 2000; 71(2): 108-17.
10. Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, et al. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant. 2011; 46(1): 77-83.
11. Arai A, Imadome K, Watanabe Y, Yoshimori M, Koyama T, Kawaguchi T, et al. Clinical features of adultonset chronic active Epstein-Barr virus infection: a retrospective analysis. Int J Hematol. 2011; 93(5): 602-9.
12. Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, et al. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol. 2011; 29(33): 4410-6.
13. Koyama M, Takeshita Y, Sakata A, Sawada A, Yasui M, Okamura T, et al. Cytotoxic chemotherapy successfully induces durable complete remission in 2 patients with mosquito allergy resulting from Epstein-Barr virusassociated T-/natural killer cell lymphoproliferative disease. Int J Hematol. 2005; 82(5): 437-40.
14. Obama K, Tara M, Niina K. L-asparaginase induced complete remission in Epstein-Barr virus positive, multidrug resistant, cutaneous T-cell lymphoma. Int J Hematol. 1999; 69(4): 260-2.
15. Nagafuji K, Fujisaki T, Arima F, Ohshima K. L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol. 2001; 74(4): 447-50.
16. Matsumoto Y, Nomura K, Kanda-Akano Y, Fujita Y, Nakao M, Ueda K, et al. Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma. Leuk Lymphoma. 2003; 44(5): 879-82.
17. Zhang Y, Nagata H, Ikeuchi T, Mukai H, Oyoshi MK, Demachi A, et al. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol. 2003; 121(5): 805-14.
18. Ando M, Sugimoto K, Kitoh T, Sasaki M, Mukai K, Ando J, et al. Selective apoptosis of natural killer-cell tumours by l-asparaginase. Br J Haematol. 2005; 130(6): 860-8.
19. Imadome K, Shimizu N, Arai A, Miura O, Watanabe K, Nakamura H, et al. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival. J Infect Dis. 2005; 192(8): 1340-8.
20. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol. 1999; 37(1): 132-6.
21. Suzuki R, Yamaguchi M, Izutsu K, Yamamoto G, Takada K, Harabuchi Y, et al. Prospective measurement of Epstein- Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type. Blood. 2011; 118(23): 6018-22.
22. Ek T, Jarfelt M, Mellander L, Abrahamsson J. Proinflammatory cytokines mediate the systemic inflammatory response associated with high-dose cytarabine treatment in children. Med Pediatr Oncol. 2001; 37(5): 459-64.
23. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virusinfected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997; 100(8): 1969-79.